Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,240 | 409 | 99.8% |
| Education | $11.71 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,445 | 74 | $0 (2024) |
| Novo Nordisk Inc | $958.06 | 52 | $0 (2023) |
| Lilly USA, LLC | $826.44 | 49 | $0 (2023) |
| GlaxoSmithKline, LLC. | $418.76 | 29 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $404.96 | 26 | $0 (2023) |
| PFIZER INC. | $348.21 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $309.76 | 16 | $0 (2023) |
| Radius Health, Inc. | $243.51 | 10 | $0 (2024) |
| Abbott Laboratories | $233.37 | 13 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $221.32 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $126.13 | 5 | ABBVIE INC. ($34.64) |
| 2023 | $2,298 | 138 | ABBVIE INC. ($481.66) |
| 2022 | $2,162 | 137 | ABBVIE INC. ($563.46) |
| 2021 | $2,665 | 130 | Novo Nordisk Inc ($599.76) |
All Payment Transactions
410 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/15/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/15/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 02/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $34.64 | General |
| Category: NEUROSCIENCE | ||||||
| 01/04/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: Endocrinology | ||||||
| 12/22/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2023 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Diabetes | ||||||
| 12/20/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: RESPIRATORY | ||||||
| 12/20/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $1.01 | General |
| Category: RESPIRATORY | ||||||
| 12/15/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Diabetes Care | ||||||
| 12/14/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: PAIN | ||||||
| 12/14/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $1.26 | General |
| Category: PAIN | ||||||
| 12/12/2023 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Diabetes | ||||||
| 12/11/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Gastroenterology | ||||||
| 12/07/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/07/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: RESPIRATORY | ||||||
| 11/30/2023 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: Endocrinology | ||||||
| 11/30/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $4.78 | General |
| Category: Diabetes | ||||||
| 11/28/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Respiratory | ||||||
| 11/21/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $32.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/16/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: PAIN | ||||||
| 11/15/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Diabetes | ||||||
| 11/13/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $27.72 | General |
| Category: Neurology | ||||||
| 11/02/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 45 | 46 | $7,273 | $1,776 |
| 2022 | 5 | 149 | 165 | $23,445 | $6,283 |
| 2021 | 2 | 34 | 38 | $5,512 | $1,662 |
| 2020 | 1 | 12 | 12 | $1,440 | $88.62 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 35 | $5,040 | $1,289 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 11 | $2,233 | $487.44 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 72 | $9,792 | $2,744 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 60 | $11,706 | $2,393 | 20.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 11 | 11 | $880.00 | $753.94 | 85.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 11 | 11 | $451.00 | $301.62 | 66.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 11 | $616.00 | $89.87 | 14.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 21 | $2,520 | $841.49 | 33.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 17 | $2,992 | $820.26 | 27.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 12 | $1,440 | $88.62 | 6.2% |
About Anna Cattau, NP
Anna Cattau, NP is a Family healthcare provider based in Lenexa, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2013. The National Provider Identifier (NPI) number assigned to this provider is 1932532629.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anna Cattau, NP has received a total of $7,251 in payments from pharmaceutical and medical device companies, with $126.13 received in 2024. These payments were reported across 410 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($7,240).
As a Medicare-enrolled provider, Cattau has provided services to 240 Medicare beneficiaries, totaling 261 services with total Medicare billing of $9,809. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Lenexa, KS
- Active Since 08/16/2013
- Last Updated 11/02/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1932532629
Products in Payments
- UBRELVY (Drug) $599.44
- VRAYLAR (Drug) $469.30
- RYBELSUS (Drug) $452.98
- TRULICITY (Drug) $286.13
- Ozempic (Drug) $284.22
- EMGALITY (Drug) $275.27
- Tymlos (Drug) $243.51
- BREZTRI (Drug) $242.69
- XARELTO (Drug) $239.75
- QULIPTA (Drug) $227.78
- XIFAXAN (Drug) $221.32
- ELIQUIS (Drug) $218.03
- Rybelsus (Drug) $215.16
- JARDIANCE (Drug) $208.06
- EVENITY (Biological) $203.26
- MOUNJARO (Drug) $192.19
- Dayvigo (Drug) $167.42
- Vascepa (Drug) $151.42
- NURTEC ODT (Drug) $139.61
- BEXSERO (Biological) $132.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Lenexa
Amanda Merino, Dnp, DNP
Family — Payments: $5,152
Kimberly Schulmeister, Nurse Practitioner, NURSE PRACTITIONER
Family — Payments: $4,469
Christina Lavery, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $3,590
Mrs. Marcia Norwich, Arnp, ARNP
Family — Payments: $3,445
Mrs. Megan Murdock, Aprn, APRN
Family — Payments: $2,694
Mrs. Mary Powell, Arnp, Np-C, ARNP, NP-C
Family — Payments: $1,622